Healthcare Reform: The Implementation - May 6-7 (Washington, DC)

Overview 

An examination of the Affordable CareAct implementation and the future of Medicare, along with the exploration somemajor success stories in the private sector.  Our high profilespeakers represent the political and the entrepreneurial worlds, as well as theintersection of the two.

Invitationfrom YPO/WPO Healthcare Industry Network

 

REGISTRATIONAND COMPLETE DETAILS

 

Logistics

When:

May 6-7, 2013

(Noon on Monday - Noon onTuesday)

Where:

Westin Georgetown
Washington, DC

Who:

YPO/WPO Healthcare Industry Network
HBS Healthcare Alumni Association

Cost:

$795.00

 

 

Additional:

Per our custom, we willenjoy a casual user-pay dinner on Sunday night for early arrivals.

 

Proposed Agenda 

MONDAY, MAY 6

11:00am-12:00

EXECUTIVE BOARDMEETING

12:00:00-1:00

LUNCH

1:00-2:30

TED KENNEDY, JR. will lead a Marwood Group panel on currentdirections in healthcare policy including ACOs and Medicare.

 

MARWOOD PANEL

 

John Kelliher, Managing Director

 

Stephen Williams, Vice President

2:30-3:30

DR. ALICE RIVLIN, of the Brookings Institution, has served as ViceChair of the Federal Reserve, Director of the Office of Management andBudget, and Director of the Congressional Budget Office. President Obamaappointed her to his National Commission on Fiscal Responsibility and Reformwhere together with Pete Domenici she addressed Saving Medicare.

3:30-4:00

BREAK

4:00-5:00

JOHN POLANOWICZ, Secretary of the Executive Office of Health andHuman Services, Commonwealth of Massachusetts, will speak on"Massachusetts Health Reform, A Model For the Nation."

5:00-6:00

DR. ROGER MERRILL, Chief Medical Officer of Perdue Farms, willtell us how Perdue has measurably improved employee health whilesignificantly reducing healthcare costs.

6:30-7:00

RECEPTION

7:00-9:00

DINNER

 

 

TUESDAY, MAY 7

7:00-8:15

BREAKFAST

8:15-9:45

MARTINE ROTHBLATT, CEO of United Therapeutics Corporation. After shefounded and sold Sirius Satellite Radio, Martine's daughter was diagnosedwith Primary Pulmonary Hypertension. With no good treatments available,Martine set out to build a company that could develop one. Today that companyis a $3 billion pharmaceutical company.

9:45-10:00

BREAK

10:00-11:00

CHAS ROADES, Chief Research Officer of the Advisory BoardCompany, will share with us some of the research that drives the advice theyare giving healthcare providers around the world.